Impact of red blood cell transfusion on platelet aggregation and inflammatory response in anemic coronary and noncoronary patients: the TRANSFUSION-2 study (impact of transfusion of red blood cell on platelet activation and aggregation studied with flow cytometry use and light transmission aggregometry).

Impact of red blood cell transfusion on platelet aggregation and inflammatory response in anemic coronary and noncoronary patients: the TRANSFUSION-2 study (impact of transfusion of red blood cell on platelet activation and aggregation studied with flow cytometry use and light transmission aggregometry). Publié in Journal of American College of Cardiology, le 18 décembre 2013. En…

A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial).

A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial). Publié dans American Journal of Cardiology, le 01 novembre 2013. En savoir plus en consultant le site. Auteurs : Collet JP, Huber K, Cohen M, Zeymer U, Goldstein P, Pollack C Jr, Silvain J, Henry P, Varenne O, Carrié…

Optimal time for catheterization in NSTE-ACS patients with impaired renal function: insights from the ABOARD Study.

Optimal time for catheterization in NSTE-ACS patients with impaired renal function: insights from the ABOARD Study. Publié dans International Journal of Cardiology, le 10 septembre 2013. En savoir plus en consultant le site. Auteurs : Barthélémy O, Cayla G, Silvain J, O'Connor SA, Bellemain-Appaix A, Beygui F, Sideris G, Varenne O, Collet JP, Vicaut E, Montalescot G;…